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Abstract
Introduction The gold-standard treatment for symptomatic anterior skull base meningiomas is surgical resection. The
endoscope-assisted supraorbital “keyhole” approach (eSKA) is a promising technique for surgical resection of olfactory groove
(OGM) and tuberculum sellae meningioma (TSM) but has yet to be compared with the microscopic transcranial (mTCA) and the
expanded endoscopic endonasal approach (EEA) in the context of existing literature.
Methods An updated study-level meta-analysis on surgical outcomes and complications of OGM and TSM operated with the
eSKA, mTCA, and EEA was conducted using random-effect models.
Results A total of 2285 articles were screened, yielding 96 studies (2191 TSM and 1510 OGM patients). In terms of effective-
ness, gross total resection incidence was highest in mTCA (89.6% TSM, 91.1% OGM), followed by eSKA (85.2% TSM, 84.9%
OGM) and EEA (83.9% TSM, 82.8% OGM). Additionally, the EEA group had the highest incidence of visual improvement
(81.9% TSM, 54.6% OGM), followed by eSKA (65.9% TSM, 52.9% OGM) and mTCA (63.9% TSM, 45.7% OGM). However,
in terms of safety, the EEA possessed the highest cerebrospinal fluid leak incidence (9.2% TSM, 14.5% OGM), compared with
eSKA (2.1% TSM, 1.6% OGM) and mTCA (1.6% TSM, 6.5% OGM). Finally, mortality and intraoperative arterial injury were
1% or lower across all subgroups.
Conclusions In the context of diverse study populations, the eSKA appeared not to be associated with increased adverse
outcomes when compared with mTCA and EEA and offered comparable effectiveness. Case-selection is paramount in estab-
lishing a role for the eSKA in anterior skull base tumours.
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Abbreviations
TSM Tuberculum sellae meningioma
OGM Olfactory groove meningioma
eSKA Endoscope-assisted supraorbital “keyhole”
approach
EEA Expanded endoscopic endonasal approach
mTCA Microscopic transcranial approach
GTR Gross total resection
CSF Cerebrospinal fluid
WHO World Health Organization
mNOS Modified New-Castle Ottawa Scale
ICA Internal carotid arteries




The gold standard treatment for symptomatic anterior skull
base meningiomas is complete surgical resection—if possible
to do so without causing significant morbidity. Although the
traditional microscopic transcranial approach (mTCA) has
proven to be effective at removing such tumours [84, 86],
minimally invasive surgical approaches may offer the possi-
bility of reducing brain exposure and manipulation, and there-
fore increasing safety [105]. However, these less invasive
techniques are often technically challenging with steep learn-
ing curves [105]. Factors influencing case-by-case surgical
decision-making include the preservation of olfaction and vi-
sion, tumour size and location, the involvement of
neurovascular structures, surgical experience, and patient
choice [24, 86].
A previous comprehensive meta-analysis comparing the
traditional mTCA and the expanded endoscopic endonasal
approach (EEA) found similar gross total resection (GTR)
and mortality rates, with more favourable visual outcomes
but higher cerebrospinal (CSF) leak incidence with EEA
[84]. This generally corroborates with findings from other
systematic reviews in the field [24, 59, 110]. However, a third
approach—the endoscope-assisted supraorbital “keyhole” ap-
proach (eSKA)—has yet to be compared with mTCA and
EEA in the context of existing literature. This approach in-
cludes multiple variations (such as the medial supraorbital,
basal supraorbital, and lateral supraorbital approaches) that
are unified by the principle of achieving surgical control of a
deep-seated lesion whilst minimizing iatrogenic injury to the
brain (via exposure, retraction, and manipulation) [102, 107].
This is achieved through using smaller craniotomies with
smaller dural openings and may theoretically reduce post-
operative complications and length of stay, whilst improving
cosmesis, patient satisfaction and carrying lower CSF leak
rates than the EEA [102, 104, 105, 107]. However, important
limitations of the eSKA include (a) difficult visualization and
orientation of deep structures, (b) difficult (almost co-axial)
instrument control owing to instrument size and the fulcrum
effect (requiring specialized instruments), and (c) limited and
predefined surgical corridors which require extensive pre-
operative planning [102, 107]. Endoscope assistance provides
a high light intensity with wider viewing angles distal to the
craniotomy, allowing high-resolution visualization of deeper
tissues. Indeed, combined with image-guidance systems and
intra-operative adjuncts (e.g. ultrasound, MRI), endoscopes
facilitate surgical orientation and resection during keyhole ap-
proaches [102, 107].
Therefore, we updated a previous systematic review and
meta-analysis comparing mTCA with EEA and extended this
review with the eSKA for the management of olfactory
groove (OGM) and tuberculum sellae meningiomas (TSM).
Methods
In order to identify studies reporting on outcomes of surgically
treated TSMs and OGMs, we adapted our previous method-
ology [84], expanding our search to include eSKA and
updating our search to include mTCA and EEA articles pub-
lished after our last search.
Search strategy
This review was conducted in accordance with the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) Statement [81]. A search strategy was created using
the keywords “Meningioma,” “Tuberculum Sellae,” “Olfactory
Groove,” and synonyms (Appendix A). Studies were included
if they reported on (1) patients with olfactory groove (OGM) or
tuberculum sellae (TSM) meningiomas; (2) patients undergo-
ing surgery using the mTCA, EEA or eSKA approaches; and
(3) surgical outcomes and complications. Exclusion criteria in-
cluded case reports, commentaries, congress abstracts, reviews,
animal studies, studies describing a combined surgical ap-
proach (for example EEA + mTCA), studies in paediatric pa-
tients (< 18 years old), re-operations, and cadaveric studies. A
date filter was applied, with articles from 2004 to 2020 being
included—reflecting a period of the contemporary adaptation
of endoscopic and keyhole approaches and the continuous im-
provement of traditional microsurgical approaches for the rele-
vant pathologies [11, 15, 32, 106].
Both PubMed and Embase databases were searched on 19
April 2020. Duplicates were removed using Endnote X9.
Independent title and abstract screening of updated results
was performed in duplicate by two authors (DZK, HJM).
Review of full-text articles ensued according to the
inclusion/exclusion criteria. Any discrepancies in selection
were settled out by discussion and mutual agreement.
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Data extraction
Data points extracted from the included articles comprised of
patient characteristics (age, sex distribution), tumour charac-
teristics (surgical approach used, sum of sample, tumour
grade, tumour diameter or volume, follow-up length), out-
comes (GTR, visual improvement), and complications (CSF
leak, 30-day mortality, intra-operative arterial injury). World
Health Organization (WHO) grading included recording the
proportion of WHO Grade 1 tumours [72]. Of note, the grad-
ing system was revised in 2016 to include brain invasion as a
criterion to upgrade Grade 1 tumours to Grade 2 [72].
Therefore, if any studies pre-2016 reported brain invasion
amongst Grade 1 tumours, the respective tumours were
upgraded accordingly [72]. Gross total resection (GTR) re-
ferred to Simpson Grades 1 and 2 as per our original method-
ology [84, 116]. Visual improvement was in the context of
those with preoperative visual problems only. Mortality (with-
in 30 days after resection) was recorded on an all-cause basis.
Owing to the not uncommon reporting of follow-up time as
a median number of months (as opposed to mean), the esti-
mated mean number of months was calculated as per recom-
mendations of Hozo et al. [53]. Of note, in sample sizes great-
er than 25, the sample’s median follow-up is presented as the
best estimate of the mean [53].
Importantly, studies that did not report specific outcomes
for OGM/TSM and approach combination were excluded
from the final meta-analysis. These studies were considered
for qualitative analysis if the relevant the tumour (TSM or
OGM) and approach (mTCA, EEA, or eSKA) combination
of interest was > 50% of the study population [9, 48, 98, 105,
111]. Similarly, articles that grouped TSM cases with planum
sphenoidale meningiomas [3, 92] were considered for quali-
tative review only (owing to the similarity of these tumour
groups) but not included in the final meta-analysis.
Risk of bias assessment
Study quality was assessed with a modified New-Castle
Ottawa Scale (mNOS), which assesses two domains: sample
selection and outcome reporting. The modification made to
the original NOS was the exclusion of the “comparability”
domain as this is not applicable to case series [126]. The scale
is scored out of 6 (3 for selection domain, 3 for outcome
domain). Publication bias was assessed using Begg’s tests
[8] and by generating funnel plots with and without trim-
and-fill method [34].
Meta-analysis
A meta-analysis was conducted using R 3.6.1 (The R
Foundation, Austria) applying the “meta” package. Pooled
incidence (using the random-effect model method of
DerSimonian and Laird [33]) was calculated for each ap-
proach (eSKA, mTCA, EEA), tumour (TSM, OGM), and out-
come (GTR, arterial injury, visual improvement, CSF leakage,
and mortality) combination. Study heterogeneity was assessed
by calculating I-squared values [52] (I2 > 50% considered
significant) and Cochran’s Q test (p < 0.10) [36, 52].
Sensitivity analysis was performed by running the above anal-
yses on a low risk of bias sub-group (mNOS score greater than
or equal to 4).
Additionally, a univariate meta-regression was performed
to explore the effect of mean age (continuous variable) and
male percentage (continuous variable) on each approach, tu-
mour, and outcome combination. Meta-regression was only
performed if 8 or more studies were available for the outcome/
approach/tumour combination being explored. This threshold
was chosen (a deviation from the standard threshold of 10) on
a pragmatic basis, to reflect the relative paucity of literature
from the newer eSKA approach [51]. This threshold was also
applied to the performance of Begg’s test, trim-and-fill anal-
ysis, and the generation of funnel plots.
Results
Search results
In all, after removing duplicates, 2285 articles were identified
(Fig. 1). After screening for titles and abstracts, 2044 articles
were excluded and 241 full texts were reviewed to yield 96
included studies. Fifty-three TSM-only case series were in-
cluded in the meta-analysis of which 21 involved the EEA
[3, 12, 13, 17, 19, 22, 37, 41, 49, 60, 61, 63, 67, 74, 91, 92,
120, 125, 131], 37 the mTCA [1, 3, 6, 13, 20, 21, 26, 29, 38,
43, 45, 55, 60, 63, 64, 66, 68, 74–76, 78, 79, 82, 85, 88, 92, 95,
97, 98, 108, 112, 114, 120, 124, 127, 130], and 5 the eSKA
[16, 35, 41, 67, 78] with 10 of these papers covering multiple
approaches [3, 14, 41, 60, 63, 67, 74, 78, 92, 120]. Twenty-
eight OGM-only case series were included in the meta-
analysis of which 5 involved EEA [4, 28, 62, 70, 92], 24 in
mTCA [5, 7, 10, 23, 25, 27, 28, 40, 42, 44, 47, 56, 57, 70, 83,
87, 89, 96, 99, 101, 109, 117, 121, 123], 3 in eSKA [4, 39, 92],
and with 4 of these studies detailing multiple approaches [4,
28, 70, 92]. Additionally, 15 studies explored both OGM and
TSM [9, 30, 31, 50, 54, 58, 65, 93, 94, 103, 105, 113, 122,
128, 129]. Resultantly, the TSM group totalled 2191 patients
and OSM group totalled 1519 patients (Tables 1 and 2).
General characteristics
The median number of patients per study was 20 (range: 3–
95) for TSM and 19.5 (range: 2–129) for OGM. The average
percentage of male patients was 24% for TSM and 31% for
OGM. The median mean of age was 54.2 years for TSM and
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54.75 years for OGM. The median mean of follow-up time for
TSM was 32 months (reported in 55/67 studies) for and 44.5
months for OGM studies (reported in 39/43 studies). The
modified NOS score varied between 2/6 and 6/6 amongst
the TSM and OGM case series, with predominant factors af-
fecting this variance being a description of follow-up and out-
come reporting. Summary characteristics by approach (eSKA,
EEA, or mTCA) are highlighted in Tables 1 and 2. Individual




GTR was reported in 10 eSKA (112 patients), 22 EEA (429
patients), and 38 mTCA (1381 patients) studies. Pooled inci-
dence of GTR (Fig. 2; Appendix C) was highest in the mTCA
group at 89.56% (95% CI 87.04–92.08) followed by eSKA at
85.21% (95% CI 73.96–96.46) and EEA at 83.95% (95% CI
79.28–88.63). Study heterogeneity was significant within the
Fig. 1 PRISMA flowchart
detailing search strategy and
systematic article selection
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eSKA (I2 = 68%, Cochran’s p < 0.01) and mTCA (I2 = 60%,
Cochran’s p < 0.01) groups, with Begg’s test for publication
bias also significant in this mTCA group (p < 0.01) (Table 3).
This impacted funnel plot asymmetry, which was most
marked in the mTCA group, without any major change in
summary effect using trim and fill across subgroups
(Appendix D). Meta-regression suggests male sex was signif-
icantly associated with lower GTR incidence in EEA (slope −
0.05 (95%CI − 0.96–0.04)) and mTCA (slope − 0.27 (95%CI
− 0.53 to − 0.01)) subgroups (Table 3).
Olfactory groove meningioma
GTR incidence was reported in 8 eSKA (75 patients), 9
mTCA (100 patients), and 28 mTCA (1295 patients) studies.
The pooled incidence of GTR (Fig. 3; Appendix C) was
highest in the mTCA group with 91.08% (95% CI 87.91–
94.24), followed by eSKA with 84.9% (95% CI 50.42–100)
and EEA at 82.78% (95% CI 72.3–93.26). In terms of study
heterogeneity, this was significant within the eSKA (I2 = 98%,
Cochran’s p < 0.01) and mTCA (I2 = 81%, Cochran’s p
<0.01) groups, with Begg’s test for publication bias also sig-
nificant in this mTCA group (p < 0.01) (Table 4). These find-
ings are similar to those of the TSM group. Funnel plot asym-
metry was most marked in mTCA (reflective of heterogeneity
and publication bias) and eSKA (likely reflective of heteroge-
neity groups). There was no major change in summary effect
using trim-and fill-method across subgroups (Appendix D). In
the eSKA subgroup, older age was associated with increased




Pre-operative visual impairment was reported in 6 eSKA (77
patients), 19 EEA (366 patients), and 36 mTCA (1280
Table 1 Summary study characteristics for tuberculum sellae meningioma papers. WHO: World Health Organisation, mNOS: modified Newcastle
Ottawa Score
Endoscopic endonasal approach Endoscope-assisted supraorbital
keyhole approach
Microscopic transcranial approach
Amount Data unavailable Amount Data unavailable Amount Data unavailable
Aggregate number of studies 26 - 11 - 42 -
Total number of patients 540 - 128 - 1523 -
Median mean age (years) 54.4 4 studies 57 1 study 53.8 8 studies
Median male % 25% 4 studies 16.7% 2 studies 23.4% 5 studies
Median number of WHO grade 1 20 15 studies 11.5 5 studies 26.5 26 studies
Median mean tumour diameter (cm) 2.5 (7 studies) 9 studies 2.9 (2 studies) 2 studies 2.5 (17 studies) 17 studies
Median mean tumour volume (cm3) 6.1 (10 studies) 12.4 (7 studies) 8.2 (8 studies)
Median mean follow-up (months) 27 6 studies 39.8 1 study 39.5 5 studies
Median mNOS score 4 - 5 - 4 -
Table 2 Summary study characteristics for olfactory groove meningioma papers. WHO: World Health Organisation, mNOS: modified Newcastle
Ottawa Score
Endoscopic endonasal approach Endoscope-assisted supraorbital
keyhole approach
Microscopic transcranial approach
Amount Data unavailable Amount Data unavailable Amount Data unavailable
Aggregate number of studies 10 - 9 - 29 -
Total number of patients 115 - 96 - 1308 -
Median mean age (years) 53.1 1 studies 59.2 1 studies 54 4 studies
Median male % 22.5% 2 studies 57.1% 2 studies 32.4% 3 studies
Median number of WHO grade 1 9 5 studies 8.5 7 studies 48 13 studies
Median mean tumour diameter (cm) 4 (1 study) 4 studies NA 3 studies 4.6 (15 studies) 10 studies
Median mean tumour volume (cm3) 33.3 (5 studies) 24.8 (6 studies) 42.5 (4 studies)
Median mean follow-up (months) 35.3 2 studies 5 1 studies 54 1 studies
Median mNOS score 4.5 - 45.1 - 4 -
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Fig. 2 Graphical display of pooled random effects per outcomemetric for Tuberculum SellaeMeningioma. EEA: Expanded endonasal approach, eSKA:
Endoscope assisted supra-orbital keyhole approach, mTCA: Microscopic transcranial approach, CI: Confidence Interval
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patients) studies. The pooled incidence of visual improvement
(Fig. 2; Appendix C) in the EEA group was 81.98% (95% CI
71.94–92.02) and was higher than the eSKA at 65.98% (95%
CI 54.4–77.56) and mTCA at 63.9% (95% CI 57.15–70.65).
However, study heterogeneity was significant within the EEA
(I2 = 88%, Cochran’s p < 0.01) and mTCA (I2 = 89%,
Cochran’s p < 0.01) groups. Publication bias was not evident
on Begg’s testing, with mild funnel plot asymmetry in mTCA
and EEA groups likely due to heterogeneity. This is supported
by the lack of its major change in summary effect using trim-
and-fill across subgroups (Appendix D). Meta-regression on
age and sex did not reach statistical significance across
mTCA, EEA, and eSKA groups (Table 3).
Olfactory groove meningioma
Pre-operative visual impairment was reported in 2 eSKA (12
patients), 6 EEA (30 patients), and 11 mTCA (236 patients)
studies. The pooled incidence of visual improvement (Fig. 3;
Appendix C) in descending order were as follows: EEA at
54.56% (95% CI 20.4–88.73), eSKA at 52.93% (95% CI 0–
100) and mTCA with 45.71% (95% CI 24.54–66.88)—a
similar pattern to the TSM group. Study heterogeneity was
significant across all subgroups: EEA (I2 = 85%, Cochran’s
p < 0.01), eSKA (I2 = 93%, Cochran’s p < 0.01), and mTCA
(I2 = 95%, Cochrans p < 0.01). Publication bias was evident in
the EEA cohort (Begg test, p = 0.04), with both this and the
above heterogeneity contributing to the marked funnel plot
asymmetry (Appendix D). Using the trim and fill method does
not display a marked difference in summary effects
(Appendix D). Meta-regression on age and sex did not reach
statistical significance across subgroups (Table 4).
Cerebrospinal fluid leakage
Tuberculum sellae meningioma
Incidence of postoperative CSF leakage was reported in 9
eSKA (108 patients), 23 EEA (473 patients), and 32 mTCA
(1182 patients) studies. The pooled incidence of CSF leak
(Fig. 2; Appendix C) in the EEA group was 9.19% (95% CI
5.33–13.05), which was higher than the incidence observed
among the eSKA treated group at 2.11% (95%CI 0–5.84) and
mTCA treated group at 1.58% (95%CI 0.68–2.48). However,
Table 3 Outcomes of the tuberculum sellae meningioma (TSM)—meta-regression based on age and male percentage. CI – confidence interval, NA –
not available
Outcomes in TSM Begg’s test
(p-value)
Meta-regression on








(Simpson Grade 1 Or 2)
Expanded endonasal approach 0.32 0.003 (− 0.006–0.01) 0.51 − 0.5 (− 0.96–0.04) 0.33
Endoscope-assisted supraorbital
keyhole approach
0.32 0.03 (− 0.01–0.06) 0.06 − 0.75 (− 1.75–0.26) 0.14
Microscopic transcranial approach < 0.01 0.001 (− 0.005–0.007) 0.75 − 0.27 (− 0.53 - − 0.01) 0.04
Visual improvement
Expanded endonasal approach 0.67 − 0.005 (− 0.01–0.005) 0.36 − 0.38 (− 0.82–0.06) 0.09
Endoscope-assisted supraorbital
keyhole approach
NA NA NA NA NA
Microsopic transcranial approach 0.35 − 0.005 (− 0.02–0.01) 0.57 0.11 (− 0.68–0.91) 0.78
Cerebrospinal fluid leak
Expanded endonasal approach 0.03 − 0.001 (− 0.008–0.008) 0.95 − 0.04 (− 0.47–0.39) 0.86
Endoscope-assisted supraorbital
keyhole approach
0.21 − 0.001 (− 0.01–0.01) 0.83 − 0.08 (− 0.47–0.31) 0.7
Microscopic transcranial approach < 0.01 0.001 (− 0.003–0.004) 0.75 0.07 (− 0.04–0.18) 0.23
Intra-operative arterial injury
Expanded endonasal approach < 0.01 0.001 (− 0.004 to − 0.004) 0.88 − 0.02 (− 0.21–0.17) 0.84
Endoscope-assisted supraorbital
keyhole approach
0.01 − 0.001 (− 0.008–0.008) 0.95 0.01 (− 0.33–0.35) 0.95
Microsopic transcranial approach < 0.01 − 9.53 (− 0.002–0.002) 0.91 − 0.006 (− 0.07–0.06) 0.87
30-day mortality
Expanded endonasal approach < 0.01 0.002 (− 0.003–0.006) 0.48 0.04 (− 0.18–0.26) 0.74
Endoscope-assisted supraorbital
keyhole approach
< 0.01 0.001 (− 0.007–0.009) 0.87 − 0.02 (− 0.36–0.3) 0.87
Microsopic transcranial approach < 0.01 0.001 (− 0.001–0.002) 0.57 − 0.001 (− 0.07–0.07) 0.99
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Fig. 3 Graphical display of pooled random effects per outcome metric for Olfactory GrooveMeningioma. EEA: Expanded endonasal approach, eSKA:
Endoscope assisted supra-orbital keyhole approach, mTCA: Microscopic transcranial approach, CI: Confidence Interval
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study heterogeneity (I2 = 49%, Cochran’s p < 0.01) and pub-
lication bias (Begg’s p=0.03) were significant in the EEA
group. Publication bias was also evident in the mTCA group
(Begg’s p ≤ 0.01). The asymmetry of mTCA and EEA funnel
plots is explained by the above (Appendix D), but no major
change in summary effect using the trim-and-fill method is
appreciable in these groups. Meta-regression on age and sex
did not reach statistical significance across any group
(Table 3).
Olfactory groove meningioma
Incidence of post-op CSF leakage was reported in 7 eSKA (58
patients), 9 EEA (109 patients), and 26 mTCA (1132 patients)
studies. Pooled incidence of CSF leak (Fig. 3; Appendix C) in
the EEA group was 14.46% (95%CI 4.82–24.1), 6.45% in the
mTCA group (95% CI 3.95–8.95), and 1.61% (95% CI 0–
7.27) in the eSKA group. Study heterogeneity was evident
in the mTCA group (I2 = 76%, Cochran’s p < 0.01), whilst
publication bias was suggested in the mTCA (Begg’s p ≤
0.01) and eSKA (Begg’s p = 0.03). Indeed, mTCA and
eSKA funnel plots reflect this in their asymmetry (Appendix
D). Meta-regression suggested male sex was associated with




Incidence of intraoperative arterial injury was reported in 11
eSKA (128 patients), 22 EEA (426 patients), and 32 mTCA
(1262 patients) studies. Pooled incidence (Fig. 2; Appendix C)
in descending order were as follows: eSKA − 0.56% (95% CI
0–3.48), EEA − 0.26% (95%CI 0–1.34), and mTCA − 0.16%
(95% CI 0–0.72). Across all 3 groups, study heterogeneity
was not apparent; however, publication bias using Begg’s test
reached statistical significance in eSKA (p = 0.01), EEA (p <
0.01), and mTCA (p < 0.01) groups—explaining funnel plot
asymmetry across groups. Trim and fill adjustment, however,
made almost no difference in overall summary effects
(Appendix D). Meta-regression did not reveal significant as-
sociations for age and sex across all treatment groups
(Table 3).
Table 4 Outcomes of the olfactory groove meningioma (OGM): Meta-regression based on age and male percentage. CI - confidence interval, NA –
Not available
Outcomes in OGM Begg’s test (p-value) Meta-regression on




sex slope (95% CI)
Meta-regression
on sex (p-value)
Gross total resection (Simpson Grade 1 Or 2)
Expanded endonasal approach 1 − 0.01 (− 0.02–0.01) 0.45 − 0.3 (− 1.34–0.74) 0.58
endoscope-assisted supraorbital
keyhole approach
0.51 0.05 (0.02–0.08) < 0.01 − 0.28 (− 2.29–1.71) 0.78
Microsopic transcranial approach 0.01 0.01 (− 0.01–0.01) 0.49 − 0.01 (− 0.29–0.28) 0.96
Visual improvement
Expanded endonasal approach 0.04 − 5.07 (− 0.04–0.04) 0.99 0.3 (− 3.3–3.9) 0.87
Endoscope-assisted supraorbital
keyhole approach
NA NA NA NA NA
Microsopic transcranial approach 0.48 0.03 (− 0.06–0.12) 0.55 − 0.47 (− 3.25–2.3) 0.74
Cerebrospinal fluid leak
Expanded endonasal approach 0.64 − 0.002 (− 0.02–0.01) 0.85 0.79 (0.2–1.38) 0.01
Endoscope-assisted supraorbital
keyhole approach
NA NA NA NA NA
Microsopic transcranial approach 0.01 − 0.002 (− 0.009–0.005) 0.51 0.001 (− 0.23–0.23) 0.99
Intra-operative arterial injury
Expanded endonasal approach 0.02 0.001 (− 0.001–0.01) 0.86 0.08 (− 0.29–0.44) 0.68
Endoscope-assisted supraorbital
keyhole approach
NA 0 (− 0.008–0.008) 1 0 (− 0.24–0.24) 1
Microsopic transcranial approach 0.01 − 4.56 (− 0.002–0.001) 0.95 − 0.01 (− 0.08–0.05) 0.68
30-day mortality
Expanded endonasal approach 0.01 0 (− 0.01–0.01) 1 0 (− 0.35–0.35) 1
Endoscope-assisted supraorbital
keyhole approach
0.01 − 0.001 (− 0.008–0.007) 0.97 − 0.06 (− 0.33–0.21) 0.66
Microsopic transcranial approach 0.01 − 0.001 (-0.003–0.001) 0.07 − 0.09 (− 0.16–0.02) 0.01
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Olfactory groove meningioma
Incidence of intraoperative arterial injury was reported in 9
eSKA (96 patients), 10 EEA (115 patients), and 27 mTCA
(1142 patients) studies. Pooled incidence (Fig. 3; Appendix C)
was highest in the EEA group at 1.25% (95% CI 0–4.32),
followed by the mTCA at 0.15% (95% CI 0–0.7) and eSKA
with 0% (95% CI 0–3.52). Indeed, these results do not align
with the TSM group. Across all 3 groups, study heterogeneity
was not apparent; however, publication bias using Begg’s test
reached statistical significance in EEA (p = 0.02) and mTCA
(p < 0.01) groups, mapping to funnel plot asymmetry in EEA
and mTCA groups. However, trim and fill adjustment made
only minor differences to the estimated summary effect
(Appendix D). Again, meta-regression did not show a signif-
icant effect of age and sex on arterial injury (Table 4).
30-day mortality
Tuberculum sellae meningioma
Incidence of mortality was reported in 11 eSKA (128 pa-
tients), 23 EEA (471 patients), and 37 mTCA (1283 patients)
studies. Pooled incidence of 30-day mortality (Fig. 2;
Appendix C) was 0.6% (95% CI 0–1.74) in the EEA group,
followed by 0.56% (95% CI 0–1.2) in mTCA and 0.33%
(95% CI 0–3.21) in eSKA in descending order. Across all 3
groups, study heterogeneity was not apparent; however, pub-
lication bias using Begg’s test reached statistical significance
in all three groups (p < 0.01). Resultantly, the mTCA and
eSKA funnel plots are asymmetrical but are not appreciably
impacted in terms of summary effect by the implementation of
trim and fill (Appendix D). Meta-regression did not show a
significant effect of age and sex onmortality across subgroups
(Table 3).
Olfactory groove meningioma
Incidence of mortality was reported in 9 eSKA (96 patients),
10 EEA (115 patients), and 23 mTCA (471 patients) studies.
Unlike, the TSM population, pooled incidence of 30-day mor-
tality (Fig. 3; Appendix C) was greatest in the mTCA group at
0.89% (95% CI 0.21–1.57), followed by the eSKA at 0.45%
(95% CI 0–4.09) and EEA with 0% (95% CI 0–2.38). Across
all 3 groups, study heterogeneity was not apparent; however,
publication bias using Begg’s test reached statistical signifi-
cance in all groups (p < 0.1), mapping to funnel plot asymme-
try in EEA and mTCA groups (Appendix D). Trim and fill
implementation did not result in any major adjustment to the
estimated summary effect. Male sex appeared to be associated
with higher 30-day mortality in the mTCA (slope − 0.09 (95%
CI − 0.016–0.02)) (Table 4).
Sensitivity analysis with low risk of bias studies
The pooled incidence of surgical outcomes of a subgroup of
low-risk studies (defined as mNOS score greater than or equal
to 4) is presented in Appendix E. This analysis, when compared
with the total group analysis, yielded overall similar results for
GTR, mortality, and intraoperative arterial injury. CSF leak in-
cidence after EEA was apparently lower (in both OGM and
TSM), and visual improvements after EEA (in the TSM group)
were more marked in the lower risk of bias studies.
Discussion
Principle findings
In the context of heterogeneous study populations and outcome
reporting, the endoscope-assisted supraorbital “keyhole” ap-
proach appeared to be associated with similar effectiveness
(GTR, visual improvement) and safety (CSF leak, 30-day mor-
tality) compared with the mTCA and EEA alternatives based
on our findings. Case selection and an understanding of relative
indications are important in selecting the most appropriate ap-
proach for anterior skull base meningioma resection.
As previously found, the EEA was associated with the
highest rates of visual improvement across OGM and TSM
groups. However, this advantage of EEA may be offset when
considering the safety profile of the three approaches, with the
EEA having the highest incidence of post-op CSF leak (statis-
tically significant in the TSM sub-group). In contrast, the
mTCA had a slightly higher incidence of GTR than eSKA
and EEA (eSKA > EEA) across TSM and OGM groups.
Interestingly, the eSKA displays intermediate results in terms
of efficacy (GTR and visual improvement) and complications
(CSF leak). Results for intra-operative arterial injury and 30-
day mortality incidences are similar and overlapping across the
3 approaches. Indeed, the eSKA, as a relatively new technique,
is less well explored. When compared with the mTCA, the
eSKA—as a minimally invasive technique—offers a smaller
craniotomy scar, less brain exposure, and less brain/nerve re-
traction [105]. Thus, theoretically, it shares similar limitations
to the minimally invasive EEA [92]—potentially making total
resection of larger tumours or tumours with significant local
invasion difficult [24, 92, 105]. However, when performedwith
the benefit of neuronavigation, neuroendoscopy (12/13 of
eSKA studies in our meta-analysis), and appropriate surgical
training, the eSKA has been used to resect relatively large tu-
mours of the anterior skull base [4, 41, 67, 105].
All 3 approaches likely have their own role in the manage-
ment of anterior skull base meningiomas, with their varying
safety and efficacy profiles as evidenced above. Case selection
will be paramount in establishing a role for each technique/
combination of techniques [4, 92, 105]. Indeed, case selection
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of eSKA is currently considerably variable, owing to its novelty
and ongoing refinement [70, 92]. The selection of the preferred
approach for each case must be taken in the context: (a) patient-
related factors (demographic, presentation, preferences), (b)
tumour-related factors (size, consistency, extension, location—
such as relation to optic foramen or cribriform plate), and (c)
surgeon experience, surgeon preference, and surgical goals (such
as GTR or STR, visual or olfactory preservation) [2, 77, 92, 105,
118]. Ottenhausen et al. presents a concise decision-making al-
gorithm (based on tumour anatomy and resulting functional def-
icits), which incorporates the specific characteristics of eSKA,
EEA, and mTCA approaches [92]. In this algorithm, the eSKA
is suitable for TSMs with lateral extension up to the internal
carotid arteries (ICA) and anterior clinoid processes (ACP), or
lateral extension beyond the lamina papyracea (LP).
Additionally, the eSKA is suggested for OGMs with (1) pre-
served olfaction and (2) disrupted olfaction without cribriform
plate invasion but with significant anterior (up to the frontal
sinus) or lateral extension. In contrast, the EEA is proposed for
TSM without significant lateral extension (ICA/ACP/LP as
above) and OGMs without significant lateral extension (where
olfaction is disrupted). Finally, an mTCA or a combined EEA +
eSKA approach is suggested for OGMs and TSMs with a sig-
nificant anterior or lateral extension (unless there is no cribriform
plate invasion, in which case, eSKA alonemay be possible) [92].
Of note, other algorithms cite > 5mm sellar extension and optic
canal involvement as factors favouring EEA in TSM [60].
During EEA for TSM, decompression of the optic canal from
below avoids excessive vascular manipulation, can be achieved
before or after tumour resection, and is well suited to tumours
with extension into the inferomedial aspect of the optic canal [2,
69]. Decompression of the involved optic canal is described in
mTCA approaches with early decompression (before tumour
resection) favoured [20, 80, 90]. In eSKA, studies describe both
early and late bilateral canal decompression with optimum
timing being less clear [16, 67]. More generally, within the liter-
ature, consensus for the ideal surgical approach in various con-
texts is not clear [41, 60, 67, 74, 92, 99]. Indeed, in light of the
COVID-19 pandemic—which elucidated to the risk endonasal
surgery may pose (exposing theatre staff to high viral loads and
potentially serious infection)—this case selection process is like-
ly to be a dynamic field in the near future [71, 100, 119].
Findings in the context of other syntheses
Previous meta-analyses have compared the EEA and mTCA
(not eSKA) with varying results.
In terms of GTR, Muskens et al. (co-author) previously
found higher GTR incidence with mTCA in OGM at 88.5%
(CI 85.9–90.7%) versus EEA 70.9% (CI 60.3–79.9%) [84]—
in line with our findings. This corroborates with other meta-
analyses. Ruggeri et al. explored OGM and TSM, finding a
higher GTR rate (p < 0.01) in mTCA (88.13%) than EEA
(78,42%) [110]. Similarly, Komotor et al. highlighted a
92.8% GTR rate in mTCA, compared with 63.2% in EEA
(0.001) in the context of TSM and OGM [59], whilst Shetty
et al. explored GTR in OGM, finding a significantly (p < 0.01)
higher rate in mTCA (90.9%) than in EEA (70.2%) [115].
Regarding visual outcomes, a recent comparative meta-
analysis by Lu et al. suggests improved visual outcome in
OGM resection using the EEA (vs. mTCA) (OR, 0.318; p =
0.04) but not statistically significant in TSM [73]. This is slightly
different from our updated findings and previous findings of
Muskens et al. [84], in which the visual outcome advantage of
EEA was most prominent in the TSM group. In other analyses,
an early (2013) study by Clark et al. displayed higher (p < 0.01)
visual improvement incidence in TSM with EEA (50–100 % in
included studies) comparedwithmTCA studies (25–78%) [24].
Shetty et al. explored OGM alone and found 80.7% visual im-
provement in the EEA studies group versus 12.83% in the
mTCA group (p < 0.01) [115]. Ruggeri et al. replicated these
findings when takingOGMand TSMas a collective group, with
EEA displaying an 80.1% incidence visual improvement, sig-
nificantly (p < 0.01) higher than mTCA (62.2%) [110].
In terms of CSF leak rate, Muskens et al. highlighted this as
a disadvantage to the EEA in both TSM (EEA: 19.3% (95%
CI 14.1–25.8%), mTCA 5.8% (95% CI 4.3– 7.8%)) and
OGM (EEA: 25.1% (95% CI 17.5–34.8%), mTCA 10.5%
(95% CI 8.2–13.4%)) [84]. This finding is echoed throughout
relevant secondary literature, with Lu et al. highlighting a
higher CSF leak incidence in EEA (vs mTCA) in TSM (OR
3.854; p = 0.013) and Shetty et al. showcasing a 25.7% CSF
leak occurrence in EEA versus 6.3% in mTCA (p < 0.01) [73,
115]. In taking TSM and OGM, together, Komotor et al. dem-
onstrated a higher CSF leak incidence of 21.3% in EEA, com-
pared with 4.3% in mTCA (p < 0.01), whilst Ruggeri et al.
illustrated 18.84% CSF leak occurrence in EEA versus 5.95%
in mTCA (p < 0.01) [110, 115].
Finally, when considering 30-day mortality, significant as-
sociations have been difficult to establish both in our study
and the literature. Ruggeri et al. found mortality rates of 2.3%
in mTCA and 1.03% in EEA in TSM and OGM, but this did
not reach statistical significance (p = 0.154) [110]. Similarly,
differences in mortality explored by Muskens et al. were in-
conclusive in TSM (EEA: 5.2% (95% CI 3.4–10.8%), mTCA
2.7% (95%CI 1.8–4%)) and OGM (EEA: 4.3% (95%CI 1.5–
11.6%), mTCA 3.9% (95% CI 2.7–5.8%)) [84]. A similar
situation is found with intra-op arterial injury incidence with
most syntheses not highlighting significant differences, ech-
oed by our updated analysis [24, 59, 110, 115].
Limitations and strengths
The principal limitations of this study are the likely prevalent
publication bias and heterogeneity of the primary literature
synthesized, more specifically heterogeneity in the reporting
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of baseline characteristics and outcomes. This is reflected in
the I2 and Cochran Q tests highlight in Figs. 2 and 3, corrob-
orating with respective funnel charts (Appendix B).
Development of core data set, through a multi-stakeholder
consensus process for example, would be useful for future
pooled analysis in the field. Secondly, it is likely the study
populations examined are considerably variable owing to the
surgical decision-making process that informs the choice of
approach. Larger, more extensive tumours may be more likely
to undergo traditional open approaches (of which there are
many variants) in order to achieve acceptable tumour resec-
tion [84]. This is reflected in Tables 1 and 2 where larger
(diameter and/or volume) tumours are included in the
mTCA group compared with the EEA group. Unfortunately,
we were not able to perform meta-regression based on tumour
size or grade owing to heterogeneous data reporting, poten-
tially adding to confounding factors [18, 46]. Additionally, the
overwhelming majority of studies included were case series,
and thus, our interpretation of our results should be tempered
to reflect this. Finally, owing to the novelty of the approach,
there is a relative paucity in the amount of included eSKA
studies. Although overall, the results of the main analysis are
similar to that of the sensitivity analysis subgroup, the number
of low risk of bias studies analyzed is also limited. Future
studies in the field must improve on methodological design,
with an emphasis on comparative studies, in order to facilitate
more robust data synthesis.
Conclusions
In the context of diverse study populations and heterogeneous
case selection criteria, the endoscope-assisted supraorbital
keyhole approach appeared not to be associated with in-
creased adverse outcomes when compared with expanded
endonasal and traditional transcranial approaches and offered
comparable effectiveness. Case selection is paramount in es-
tablishing a role for the supraorbital keyhole approach in an-
terior skull base tumours. Development of standardized re-
search databases and well-designed comparative studies that
control for selection and confounding biases are needed to
further delineate these selection criteria.
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Comments
The authors have updated their previous meta-analysis on anterior fossa
meningiomas, recognizing that the transcranial group comprises a huge
variety of traditional approaches and newer minimally invasive tech-
niques. It is important to compare modern microsurgical approaches




Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
676 Acta Neurochir (2021) 163:661–676
